Jacques Eugene Rossouw

Jacques Eugene Rossouw's AcademicInfluence.com Rankings

Philosophy

#8869

World Rank

#12330

Historical Rank

Ontology

#106

World Rank

#119

Historical Rank

Logic

#5881

World Rank

#7328

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jacques Eugene Rossouw's Degrees

Bachelors Medicine University of Cape Town
Masters Medicine University of Cape Town
PhD Medicine University of Cape Town

Why Is Jacques Eugene Rossouw Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jacques Eugene Rossouw's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial (2002) (14635)
National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) (10068)
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. (2004) (4327)
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) (1993) (4130)
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. (1998) (2280)
Estrogen plus progestin and the risk of coronary heart disease. (2003) (2007)
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. (2007) (1330)
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. (2003) (1150)
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. (2013) (1108)
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. (2006) (873)
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. (2002) (734)
The Women's Health Initiative recruitment methods and results. (2003) (701)
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. (2006) (695)
Report of the Conference on Low Blood Cholesterol: Mortality Associations (1992) (679)
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. (2006) (646)
Estrogen therapy and coronary-artery calcification. (2007) (562)
Cholesterol reduction yields clinical benefit: impact of statin trials. (1998) (506)
Calcium plus vitamin D supplementation and the risk of breast cancer. (2008) (440)
The value of lowering cholesterol after myocardial infarction. (1990) (432)
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction (2014) (426)
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. (2008) (373)
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials (2017) (366)
The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals (2016) (347)
Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative (2006) (337)
Triglyceride, high density lipoprotein, and coronary heart disease. (1993) (335)
Cholesterol reduction yields clinical benefit. A new look at old data. (1995) (297)
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study (2012) (275)
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. (2006) (249)
Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health Initiative (2012) (247)
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. (2009) (239)
Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents. (1992) (227)
Hormones, genetic factors, and gender differences in cardiovascular disease. (2002) (218)
Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci (2016) (214)
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. (2008) (151)
Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction (2014) (147)
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. (2008) (129)
Vasomotor symptoms and cardiovascular events in postmenopausal women (2011) (128)
Risk Factors for Incident Hospitalized Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal Women (2016) (128)
The evolution of the Women's Health Initiative: perspectives from the NIH. (1995) (123)
Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. (2010) (121)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary. (2004) (119)
Lipid-lowering interventions in angiographic trials. (1995) (113)
Coronary risk factor screening in three rural communities. The CORIS baseline study. (1983) (105)
The effect of skim milk, yoghurt, and full cream milk on human serum lipids. (1981) (104)
Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. (2013) (97)
Hormone replacement therapy and cardiovascular disease. (1999) (96)
Approaches to monitoring the results of long-term disease prevention trials: Examples from the Women's Health Initiative (1996) (88)
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. (2008) (88)
Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies. (2017) (87)
Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women’s Health Initiative Observational Study (2014) (82)
Community-based intervention: the Coronary Risk Factor Study (CORIS). (1993) (79)
Low or lowered cholesterol and risk of death from suicide and trauma. (1993) (78)
Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling (2010) (74)
Estrogens for prevention of coronary heart disease. Putting the brakes on the bandwagon. (1996) (73)
Hypertension, Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study. (2016) (70)
Vitamin B6 deficiency in chronic liver disease--evidence for increased degradation of pyridoxal-5'-phosphate. (1977) (67)
Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study (2008) (64)
Variation in the FGFR2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer (2009) (62)
Coronary Heart Disease in Postmenopausal Recipients of Estrogen Plus Progestin Therapy: Does the Increased Risk Ever Disappear? (2010) (59)
Both Light Intensity and Moderate‐to‐Vigorous Physical Activity Measured by Accelerometry Are Favorably Associated With Cardiometabolic Risk Factors in Older Women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study (2017) (59)
Lipoprotein Particle Concentrations May Explain the Absence of Coronary Protection in the Women's Health Initiative Hormone Trials (2008) (58)
Low-fat dietary pattern and cardiovascular disease: results from the Women's Health Initiative randomized controlled trial. (2017) (58)
Selenium and other mineral elements in populations at risk for esophageal cancer (1988) (58)
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials (2014) (55)
Smoking and diabetes: does the increased risk ever go away? (2013) (55)
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2020) (53)
Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative Dietary Modification Trial. (2010) (52)
Coronary risk factors in the coloured population of the Cape Peninsula. (1985) (51)
Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health Initiative (2018) (50)
Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events. (2008) (50)
Vasomotor symptoms and coronary artery calcium in postmenopausal women (2010) (46)
Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative (2013) (45)
Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial (2014) (44)
Prevalence of overweight and obesity and its relation to coronary heart disease in the CORIS study. (1988) (44)
SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function. (2017) (44)
Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease (2005) (44)
Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings (2009) (44)
Effect of Breast Feeding on the Plasma Cholesterol and Growth of Infants (1991) (43)
Twelve-year results of the Coronary Risk Factor Study (CORIS). (1997) (43)
Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. (2013) (41)
Postmenopausal estrogen and progestin effects on the serum proteome (2009) (41)
Hypertension in the coloured population of the Cape Peninsula. (1986) (40)
The hormone therapy dilemma: women respond. (2003) (40)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials. (2004) (35)
Drop-out and newcomer bias in a community cardiovascular follow-up study. (1990) (34)
Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones. (2005) (34)
Promotion and regression of atherosclerosis in vervet monkeys by diets realistic for westernized people. (1987) (33)
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis from the women’s health initiative observational study (2003) (32)
The effect of creatine monohydrate loading on maximal intermittent exercise and sport-specific strength in well trained power-lifters (2000) (32)
Effect of postmenopausal hormone therapy on cardiovascular risk. (2002) (32)
Dietary fat and breast cancer (1993) (31)
Intake of macronutrients and their relationship with total cholesterol and high-density lipoprotein cholesterol. The Coronary Risk Factor Study, 1979. (1988) (31)
Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists (2007) (30)
Kwashiorkor in North America. (1989) (29)
Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes (2019) (28)
Action limits for serum total cholesterol. A statement for the medical profession by an ad hoc committee of the Heart Foundation of Southern Africa. (1988) (28)
Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy (2019) (28)
The effects of lowering serum cholesterol on coronary heart disease risk. (1994) (27)
Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials (2018) (27)
Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases (2013) (27)
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects (2014) (27)
The prevalence of ischaemic heart disease in three rural South African communities. (1984) (27)
Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims. (2017) (25)
Deaths from injury, violence, and suicide in secondary prevention trials of cholesterol lowering. (1991) (24)
Serum total and high-density lipoprotein cholesterol--reference values obtained in the Coronary Risk Factor Study baseline survey. (1985) (24)
Anthropometric profile of the coloured population of the Cape Peninsula. (1990) (24)
Smoking cessation, weight gain, and risk of type 2 diabetes mellitus among postmenopausal women. (2012) (24)
Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials (2007) (23)
Variation in the FGFR2 Gene and the Effect of a Low-Fat Dietary Pattern on Invasive Breast Cancer (2010) (23)
The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials (2014) (22)
Change in Physical Activity and Sitting Time After Myocardial Infarction and Mortality Among Postmenopausal Women in the Women's Health Initiative‐Observational Study (2017) (22)
Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk? (2013) (21)
Using the Whole Cohort in the Analysis of Case-Control Data (2013) (21)
Hepatic complications of antituberculous therapy. (1975) (21)
Prevalence of familial hypercholesterolaemia in three rural South African communities. (1986) (20)
Relationships of Coronary Heart Disease With 27-Hydroxycholesterol, Low-Density Lipoprotein Cholesterol, and Menopausal Hormone Therapy (2012) (20)
Associations of Biomarker-Calibrated Sodium and Potassium Intakes With Cardiovascular Disease Risk Among Postmenopausal Women (2017) (20)
Factors Associated with High Density Lipoprotein Cholesterol in a Population with High High Density Lipoprotein Cholesterol Levels (1989) (19)
Estrogen Receptor Polymorphisms and the Vascular Effects of Hormone Therapy (2011) (19)
Implications of Recent Clinical Trials of Postmenopausal Hormone Therapy for Management of Cardiovascular Disease (2006) (19)
Relationship between high density lipoprotein subfractions and coronary risk factors in a rural white population. (1990) (19)
Early risk of cardiovascular events after commencing hormone replacement therapy. (2001) (19)
The effect of L-carnitine supplementation on plasma carnitine levels and various performance parameters of male marathon athletes (1997) (19)
Does lowering serum cholesterol levels lower coronary heart disease risk? (1990) (19)
Changes in smoking during a community-based cardiovascular disease intervention programme. The Coronary Risk Factor Study. (1991) (19)
Association of Traditional Cardiovascular Risk Factors With Venous ThromboembolismClinical Perspective (2017) (18)
Coronary Artery Calcification (CAC) and Post‐Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen‐Alone Trial (2017) (18)
Red blood cell transketolase activity and the effect of thiamine supplementation in patients with chronic liver disease. (1978) (18)
Hormones for coronary disease—full circle (2002) (17)
Hypercholesterolaemia in the coloured population of the Cape Peninsula (CRISIC study). (1987) (17)
The Women's Health Initiative: recruitment complete--looking back and looking forward. (1999) (17)
Liver glycogen after portacaval shunt in rats. (1978) (17)
Therapeutic controversy: Hormone replacement therapy--where are we going? (1999) (16)
Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Ischemic Stroke due to Postmenopausal Hormone Therapy (2012) (15)
Randomized Trial Evaluation of Benefits and Risks of Menopausal Hormone Therapy Among Women Aged 50-59. (2020) (15)
The intervention effects of a community-based hypertension control programme in two rural South African towns: the CORIS Study. (1993) (15)
The influence of diet and dimethylhydrazine on the small and large intestine of vervet monkeys. (1986) (14)
The coexistence of major coronary heart disease risk factors in the coloured population of the Cape Peninsula (CRISIC study). (1990) (13)
The use of low density lipoprotein receptor activity of lymphocytes to determine the prevalence of familial hypercholesterolaemia in a rural South African community. (1989) (13)
Plasma Phospholipid Fatty Acids and Coronary Heart Disease Risk: A Matched Case-Control Study within the Women’s Health Initiative Observational Study (2019) (13)
Socio-economic status, risk factors and coronary heart disease. The CORIS baseline study. (1990) (13)
Bone mineral density of American Indian and Alaska Native women compared with non-Hispanic white women: results from the Women's Health Initiative Study (2005) (13)
Thiamine deficiency in fulminant hepatic failure and effects of supplementation. (1977) (12)
Risk Factor Burden, Heart Failure, and Survival in Women of Different Ethnic Groups: Insights From the Women’s Health Initiative (2018) (12)
Theoretical Effects of Substituting Butter with Margarine on Risk of Cardiovascular Disease (2017) (12)
Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk (2012) (12)
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk (2012) (11)
Torsion of the gallbladder-a case where the gallbladder was firmly attached to the liver. (1970) (11)
The relationship between dietary factors and serum cholesterol values in the coloured population of the Cape Peninsula. (1990) (11)
Vitamin B6 and aspartate aminotransferase activity in chronic liver disease. (1978) (11)
Change in knowledge in a coronary heart disease risk factor intervention study in three communities. (1991) (11)
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk (2011) (10)
The degradation of tryptophan in severe liver disease. (1978) (10)
Variation in the FGFR 2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer (2009) (10)
SOS 2 and ACP 1 Loci Identi fi ed through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function (2017) (9)
Plasma pyridoxal phosphate levels in fulminant hepatic failure and the effects of parenteral supplementation. (1977) (9)
The Role of Randomized Controlled Trials in Assessing the Benefits and Risks of Long‐Term Hormone Replacement Therapy: Example of the Women's Health Initiative (1996) (9)
Debate: The potential role of estrogen in the prevention of heart disease in women after menopause (2000) (9)
Approached to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative. (1996) (9)
Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50–59 Years of Age (2021) (9)
Water-soluble vitamins in severe liver disease. (1978) (9)
Of designer drugs, magic bullets, and gold standards. (1998) (8)
Informed Consent in the Women's Health Initiative Clinical Trial and Observational Study (1995) (8)
Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy (2016) (8)
Prescribing postmenopausal hormone therapy to women in their 50s in the post-Women's Health Initiative era. (2010) (8)
Smoking patterns in the coloured population of the Cape Peninsula (CRISIC study). (1987) (8)
Dual Outcome Intention-to-treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials. (2020) (8)
Study had insufficient power to investigate safety (2012) (7)
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. (2011) (7)
Hypercholesterolaemia in a rural white population and its relationship with other coronary risk factors. (1990) (7)
Relation of family history and reversible risk factors to coronary heart disease prevalence in an Afrikaner community. (1991) (6)
Nutritional epidemiology and the Women's Health Initiative: a review. (2021) (6)
Diet and heart disease in the 1980s. (1983) (6)
Reconciling the Divergent Findings from Clinical Trials and Observational Studies of Menopausal Hormone Therapy for Prevention of Coronary Heart Disease (2014) (6)
Factors Associated With New‐Onset Depression Following Ischemic Stroke: The Women's Health Initiative (2017) (6)
The nutrient intake of a group of older South African hospitalized persons. (1989) (6)
Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women (2016) (6)
Relationship between coronary-prone (type A) behaviour and other coronary risk factors in the coloured population of the Cape Peninsula. (1986) (5)
Alcohol intake in relation to lipids, lipoproteins and blood pressure. (1992) (5)
[The control of hypertension in 2 communities. An interim evaluation]. (1981) (5)
Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer (2015) (5)
A peppy response to PEPI results (1995) (5)
Lack of a relationship between plasma pyridoxal phosphate levels and ischaemic heart disease. (1985) (5)
Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: response to Neupane (2014) (5)
The relationship between alcohol consumption and coronary risk factors in the CORIS Study. (1988) (5)
Hypertension in a rural South African white population and the effect of antihypertensive treatment on the risk of coronary heart disease. (1990) (5)
Risks and Benefits of Estrogen Plus Progestin in Healthy , Postmenopausal Women : Principal Results from the Women ' s Health Initiative Randomized Controlled Trial " ( 2002 ) (2019) (5)
Chronic proximal muscular weakness in alcoholics. (1976) (4)
Apolipoprotein B levels and related factors in a rural white South African community--the CORIS study. Coronary Risk Factor Study. (1996) (4)
Calcium supplements and cardiovascular risk in the Women’s Health Initiative: response to Bolland et al. (2013) (4)
Does low cholesterol cause death? (1993) (4)
Complete heart block complicating thyrotoxicosis. (1974) (4)
Lowering cholesterol concentrations and mortality (1990) (4)
Choice of coronary heart disease risk factor variables in a cross-sectional study of white South Africans. (1990) (4)
Contributions of the Women's Health Initiative to Cardiovascular Research: JACC State-of-the-Art Review. (2022) (3)
RE : DIETARY FAT AND BREAST CANCER. RESPONSE (1993) (3)
Postmenopausal estrogen and the risk of breast cancer. The need for randomized trials. (1994) (3)
Hepatic complications of anti-tuberculous therapy. (1975) (3)
Occult gastrointestinal bleeding due to aspirin: comparison of two compounds. (1976) (3)
Plasma lipids and hepatic lipid synthesis following portacaval shunt in the rat. (1978) (3)
The effects of an L-methionine combination supplement on symptoms of upper respiratory tract infections and performance in ultramarathon runners before, during and after ultra-endurance exercise (2004) (3)
Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor (2021) (3)
Does Estrogen Have a Role in the Prevention of Cardiovascular Disease (1999) (3)
The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women (2017) (3)
Does estrogen replacement prevent coronary heart disease? (1997) (3)
Pyridoxine deficiency in severe liver disease [proceedings]. (1976) (3)
Vitamin B 6 deficiency in chronic liver disease-evidence for increased degradation of pyridoxal-5 '-phosphate (2006) (2)
Hormone Therapy and Cardiovascular Risk—Reply (2007) (2)
Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women (2018) (2)
Noakes misses the point. (2013) (2)
Women's health initiative view of estrogen avoidance and all-cause mortality. (2013) (2)
Reply to DR Merkle. (2018) (2)
A STRATEGY FOR THE PREVENTION OF CORONARY HEART DISEASE (1987) (2)
"Preventing breast cancer in postmenopausal women by achievable diet modification: a missed opportunity in public health policy" (Dayal HH and Kalia A, The Breast 2010; 19: 309-311). (2011) (2)
Menopausal Hormone Therapy and Coronary Heart Disease: Reconciling Divergent Findings from Observational Studies and Clinical Trials (2013) (2)
Mitochondrial function and free fatty acid levels in rats after portacaval shunt. (1979) (1)
Health actions and disease patterns related to coronary heart disease in the coloured population of the Cape Peninsula. (1990) (1)
Menopausal Estrogen Therapy and Breast Cancer Mortality-Reply. (2018) (1)
Abstract 20653: Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort of Women: The Women’s Health Initiative (2017) (1)
Associations of fats and carbohydrates with cardiovascular disease and mortality—PURE and simple? (2018) (1)
of macronutrients and their with total cholesterol and lipoprotein cholesterol Intake relationship high-density The Coronary Risk Factor Study, 1979 (1988) (1)
FOUR AUTHORS REPLY (2008) (1)
Lowering cholesterol to prevent reinfarction (1991) (1)
Epidemiology of Cardiovascular Disease in Women (2002) (1)
Trials for menopausal women (2004) (1)
Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases (2013) (1)
Abstract 50: Hypertension, Antihypertensive Treatment, Sodium Intake and Cognitive Decline (2015) (1)
Towards standardisation of pre- and post-analytical variables in the assessment of lipid risk factors for ischaemic heart disease. (1988) (1)
Pharmacologic therapy for high blood cholesterol levels and clinical aspects of lipid‐lowering drugs (1989) (1)
Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk (2012) (1)
The predictive ability of lipoproteins and the value of lowering plasma cholesterol in the presence of coronary heart disease (1991) (1)
Abstract 1008: Multi-marker Prediction of Coronary Heart Disease Risk: The Women's Health Initiative (2009) (1)
Directions: Report of the National Heart, Lung and Blood Institute Workshop: October 2 Women's Ischemic Syndrome Evaluation : Current Status and Future Research (2012) (0)
"Don't read my lips--read the exclusions". (1995) (0)
Lowering Cholesterol .The Secondary Prevention of Coronary Heart Disease (1992) (0)
Erratum To: Genetic variants in the MRPS30region and postmenopausal breast cancer risk (2012) (0)
Hormone therapy and cardiovascular risk. Authors' reply (2007) (0)
Correction: Genetic variants in the MRPS30 region and postmenopausal breast cancer risk (2012) (0)
Venous Thromboembolism Incidence, Recurrence, and Mortality Based on Women's Health Initiative Data and Medicare Claims (2017) (0)
Prentice et al. Respond to “Studying Co-Occurrence of Multiple Outcomes” (2020) (0)
Local epidemiology of acute myocardial infarction (1988) (0)
Postmenopausal estrogen and progestin use was associated with a lower risk of cardiovascular disease. (1997) (0)
Menopausal Hormone Therapy and Coronary Heart Disease: Reconciling Divergent Findings from Observational Studies and Clinical Trials (2012) (0)
Abstract MP39: Plasma Phospholipid Fatty Acid and Coronary Heart Disease Risk (2016) (0)
Th-W59:1 Postmenopausal hormone therapy-lessons from the women's health initiative (2006) (0)
Estrogen replacement therapy in postmenopausal women does not have clear beneficial effect on progression of coronary-artery disease (2001) (0)
[Malnutrition in 3 hospital populations]. (1981) (0)
Response to Commentary on 'Dual Outcome Intention-To-Treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials'. (2020) (0)
Abstract 16059: Racial and Ethnic Differences in Preserved Ejection Fraction and Reduced Ejection Fraction Incident Heart Failure in a Multiracial Cohort of Post-Menopausal Women (2014) (0)
Postmenopausal Hormone Therapy and Cardiovascular Disease (2007) (0)
Estrogen-progestin therapy was not effective in secondary prevention of CHD in post-menopausal women. (1998) (0)
Original Contribution Associations of Biomarker-Calibrated Sodium and Potassium Intakes With Cardiovascular Disease Risk Among PostmenopausalWomen (2017) (0)
South African community . hypercholesterolaemia in a rural prevalence of familial lymphocytes to determine the lipoprotein receptor activity of The use of low density (0)
The 2010 North American Menopause Society position statement on hormone therapy goes beyond the available evidence. (2012) (0)
Using the Whole Cohort in the Analysis of Case-Control Data (2013) (0)
Wanvoeding in drie hospitaalbevolkings (1981) (0)
Nutritional support during pregnancy (0)
Theuse oflow density lipoprotein receptoractivity oflymphocytes todetermine theprevalence of familial hypercholesterolaemia (1989) (0)
Epidemiology of Cardiovascular Disease in Women: Role of Estrogens (2002) (0)
Menopausal Hormone Therapy and Risk for Cardiovascular Disease in the WHI Trial (2010) (0)
status, risk factors disease Socio-economic and coronary heart (1990) (0)
Abstract 10030: Validation of Framingham and Reynolds Cardiovascular Risk Prediction Models in the Women's Health Initiative (2011) (0)
Risk for cardiovascular events in new users of menopausal hormone therapy (2001) (0)
profile of the coloured Cape Peninsula Anthropometric population of the (1990) (0)
Baseline Vasomotor Symptoms and Cardiovascular Events Among Postmenopausal Women Using Conjugated Equine Estrogens (CEE) or CEE Plus Medroxyprogesterone (MPA) in the Women’s Health Initiative (WHI) Clinical Trials (2005) (0)
Rare loss of function variants in candidate genes and risk of colorectal cancer (2018) (0)
between alcohol coronary risk study The relationship consumption and factors in the CORIS (1988) (0)
Long-term Hormone Replacement Therapy: A Contrary Point of View (2001) (0)
Noakes misses the point : correspondence (2013) (0)
Water-soluble vitamins and aromatic aminoacids in liver disease (1977) (0)
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects (2014) (0)
Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2021) (0)
Complementary and alternative approaches to diabetes care (2015) (0)
"Risks and Benefits of Estrogen Plus Progestin in Healthy, Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial" (2002), by Jacques Rossouw et al (2019) (0)
Estrogen, lipids, and coronary heart disease in women (2000) (0)
REYE'S SYNDROME AND THE KINETICS OF ORNITHINE CARBAMOYLTRANSFERASE (1975) (0)
Coronary Heart Disease Relationships of Coronary Heart Disease With 27-Hydroxycholesterol, Low-Density Lipoprotein Cholesterol, and Menopausal Hormone Therapy (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jacques Eugene Rossouw?

Jacques Eugene Rossouw is affiliated with the following schools:

Jacques Eugene Rossouw's Academic­Influence.com Rankings

Jacques Eugene Rossouw's Degrees

Why Is Jacques Eugene Rossouw Influential?

Jacques Eugene Rossouw's Published Works

Published Works

What Schools Are Affiliated With Jacques Eugene Rossouw?

Jacques Eugene Rossouw's AcademicInfluence.com Rankings